Larvol Delta - RayzeBio-Nominates-Glypican3-GPC3-Targeted-Radiopharmaceutical-Therapy-Drug-Candidate-for-Treatment-of-Liver-Cancer

GPC3 targeted radiopharmaceutical therapy - RayzeBio, PeptiDream

https://www.businesswire.com/news/home/20230321005105/en/RayzeBio-Nominates-Glypican-3-GPC3-Targeted-Radiopharmaceutical-Therapy-Drug-Candidate-for-Treatment-of-Liver-Cancer

Mar 21, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next